EXTH-01. MODELING THE SAFETY OF TOPICAL AGENTS FOR SKIN TOXICITY ASSOCIATED WITH TUMOR TREATING FIELDS THERAPY IN GLIOBLASTOMA

Tumor Treating Fields are low intensity, intermediate frequency, alternating electric fields that are approved for the treatment of patients with glioblastoma (GBM). TTFields are applied continuously using a set of four transducer arrays placed on the skin. The main TTFields-related adverse event is...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Lacouture, Mario, Hershkovich, Hadas, Giladi, Moshe, Bomzon, Zeev, Kirson, Eilon, Weinberg, Uri, Plati, Yoram
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216918/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.350
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky